CSIMarket


Gilead Sciences Inc   (GILD)
Other Ticker:  
 
    Sector  Healthcare    Industry Biotechnology & Drugs
   Industry Biotechnology & Drugs
   Sector  Healthcare

Gilead Sciences Inc

GILD's Fundamental analysis






Looking into Gilead Sciences Inc growth rates, revenue grew by 15.77 % in I. Quarter 2021 from the same quarter a year ago.

Biotechnology & Drugs industry recorded growth of revenues by 27.22 %

Gilead Sciences Inc 's net income grew by 11.96 % in I. Quarter 2021 year on year, above company average,

More on GILD's Growth


Gilead Sciences Inc
current PE on trailing twelve month basis is above Biotechnology & Drugs industry average.

Gilead Sciences Inc realized cash outflow of $ -4.74per share in trailing twelve-month period.
Company
295.58
PE TTM   
Industry
0
PE TTM    
Company's Price to Sales ratio is at 3.28.
Biotechnology & Drugs industry's Price to Sales ratio is at 5.28.
With annual estimated revenue growth of 19.49 % for 2015, Company's P/S ratio deteriorated to 2.85.

More on GILD's Valuation
 
 Total Debt (Millions $) 30,166
 Dividend TTM ($) 2.77 $
 Dividend Yield TTM (%) 4.37 %
 Revenue/Employee (TTM) $ 2,166,441
 Net Income/Employee (TTM) $ 23,136
 Receivable Turnover (TTM) 6.42
 Tangible Book Value (Per Share $) -19.14

Gilead Sciences Inc
current PE on trailing twelve month basis is above Biotechnology & Drugs industry average.

Gilead Sciences Inc realized cash outflow of $ -4.74per share in trailing twelve-month period.
Company
295.58
PE TTM   
Industry
0
PE TTM    
Company's Price to Sales ratio is at 3.28.
Biotechnology & Drugs industry's Price to Sales ratio is at 5.28.
With annual estimated revenue growth of 19.49 % for 2015, Company's P/S ratio deteriorated to 2.85.

More on GILD's Valuation

  Market Capitalization (Millions $) 83,973
  Shares Outstanding (Millions) 1,262
  Employees 11,800
  Revenues (TTM) (Millions $) 25,564
  Net Income (TTM) (Millions $) 273
  Cash Flow (TTM) (Millions $) -5,986
  Capital Exp. (TTM) (Millions $) -644
  Total Debt (Millions $) 30,166
  Dividend TTM ($) 2.77 $
  Dividend Yield TTM (%) 4.37 %
  Revenue/Employee (TTM) $ 2,166,441
  Net Income/Employee(TTM) $ 23,136
  Receivable Turnover Ratio (TTM) 6.42
  Tangible Book Value (Per Share $) -19.14

  Market Capitalization (Millions $) 83,973
  Shares Outstanding (Millions) 1,262
  Employees 11,800
  Revenues (TTM) (Millions $) 25,564
  Net Income (TTM) (Millions $) 273
  Cash Flow (TTM) (Millions $) -5,986
  Capital Exp. (TTM) (Millions $) -644

GILD's Profitability Comparisons
Gilead Sciences Inc achieved increase in profitability, due to cost control. Operating Margin grew in I. Quarter 2021 to 44.99 % from 35.72 % in IV. Quarter.

Gilead Sciences Inc net profit margin of 26.81 % is currently ranking no. 7 in Biotechnology & Drugs industry, ranking no. 30 in Healthcare sector and number 451 in S&P 500.


Profitability by Segment



  Ratio
   Capital Ratio (MRQ) 2.1
  Total Debt to Equity (MRQ) 1.59
  Tangible Leverage Ratio (MRQ) -
  Asset Turnover Ratio (TTM) 0.4
  Inventory Turnover Ratio (TTM) 3.6



Gilead Sciences Inc achieved increase in profitability, due to cost control. Operating Margin grew in I. Quarter 2021 to 44.99 % from 35.72 % in IV. Quarter.

Gilead Sciences Inc net profit margin of 26.81 % is currently ranking no. 7 in Biotechnology & Drugs industry, ranking no. 30 in Healthcare sector and number 451 in S&P 500.

More on GILD's Key Ratios





Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

BKU's Profile

Stock Price

BKU's Financials

Business Description

Fundamentals

Charts & Quotes

BKU's News

Suppliers

BKU's Competitors

Customers & Markets

Economic Indicators

BKU's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Indices

Sectors & Industries

Financials

Commodities

Currencies

News


At a Glance

Stocks

Economy

Industries

Other

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.    Copyright © 2021 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071